Caption Management, LLC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 161 filers reported holding ARCUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.5%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$143,600
-88.2%
8,000
-86.7%
0.00%
-90.9%
Q2 2023$1,218,600
-55.2%
60,000
-59.7%
0.02%
-57.7%
Q1 2023$2,717,760
+5375.8%
149,000
+6108.3%
0.05%
+5100.0%
Q4 2022$49,632
-99.5%
2,400
-99.4%
0.00%
-99.3%
Q2 2022$10,425,000
+125.7%
411,400
+181.1%
0.14%
+155.4%
Q1 2022$4,619,000
+315.8%
146,340
+225.9%
0.06%
+51.4%
Q2 2020$1,111,00044,9000.04%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders